Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease

Not yet recruitingOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Congenital Heart DiseaseCyanotic Congenital Heart Diseased-Transposition of the Great ArteriesHypoplastic Left Heart Syndrome
All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT06711666 - Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease | Biotech Hunter | Biotech Hunter